Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial | tctmd.com
The Effect of Cangrelor and Access Site on Ischemic and Bleeding Events – Insights from CHAMPION PHOENIX J. Antonio Gutierrez, MD, MHS, Robert A. Harrington, - ppt download
Figure S1: CHAMPION PHOENIX Study Design | Download Scientific Diagram
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
PDF) CHAMPION PHOENIX Trial
Table 1 from Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention | Semantic Scholar
Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com
Table 3 from Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials. | Semantic Scholar
Hallway Buzz: CHAMPION PHOENIX Trial with Deepak Bhatt, MD | MedPageToday
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics – The CHAMPION PHOENIX Trial | tctmd.com
PPT - CHAMPION PHOENIX PowerPoint Presentation, free download - ID:2257235
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Table 5 from Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use | Semantic Scholar
Cangrelor Superior to Clopidogrel in CHAMPION PHOENIX Trial | DAIC
The Effect of Cangrelor and Access Site on Ischemic and Bleeding Events – Insights from CHAMPION PHOENIX J. Antonio Gutierrez, MD, MHS, Robert A. Harrington, - ppt download
Consistent Reduction in MI with Cangrelor Deepak L - ppt download
CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention | JACC: Cardiovascular Interventions
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial - ScienceDirect
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial | Journal of the American College of Cardiology
Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX | tctmd.com
